NS
Article DetailSEC EDGAR Filings
首页文档检索台
SEC EDGAR Filings

8-K - Prelude Therapeutics Inc - 5.02 / 9.01

Filed: 2026-04-15 AccNo: 0001193125-26-155978 Size: 224 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits
查看原文来源主页查看事件簇按来源查看
发布时间04/15 11:41 UTC
首次发现04/15 11:45 UTC
热度107.2
重要度84
情绪-0.02

站内整理正文

优先显示结构化正文；如果正文还未抽出，则回退到摘要。
sec_edgar_index_v1 · 877 字符

Form 8-K - Current report: SEC Accession No. 0001193125-26-155978

Filing Date: 2026-04-15

Accepted: 2026-04-15 07:41:22

Documents: 11

Period of Report: 2026-04-15

Items: Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits

Prelude Therapeutics Inc (Filer) CIK : 0001678660 (see all company filings) EIN. : 811384762 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-39527 | Film No.: 26862543 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)

1 | 8-K | prld-20260415.htm iXBRL | 8-K

2 | EX-99.1 | prld-ex99_1.htm | EX-99.1

3 | GRAPHIC | img268059179_0.jpg | GRAPHIC

4 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | prld-20260415.xsd | EX-101.SCH